Molecular mechanism of ATF6 in unfolded protein response and its role in disease.
Activating transcription factor 6 (ATF6)
Endoplasmic reticulum stress (ERS)
Proteostasis
Unfolded protein response (UPR)
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
01
11
2023
revised:
04
02
2024
accepted:
05
02
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
Activating transcription factor 6 (ATF6), an important signaling molecule in unfolded protein response (UPR), plays a role in the pathogenesis of several diseases, including diseases such as congenital retinal disease, liver fibrosis and ankylosing spondylitis. After endoplasmic reticulum stress (ERS), ATF6 is activated after separation from binding immunoglobulin protein (GRP78/BiP) in the endoplasmic reticulum (ER) and transported to the Golgi apparatus to be hydrolyzed by site 1 and site 2 proteases into ATF6 fragments, which localize to the nucleus and regulate the transcription and expression of ERS-related genes. In these diseases, ERS leads to the activation of UPR, which ultimately lead to the occurrence and development of diseases by regulating the physiological state of cells through the ATF6 signaling pathway. Here, we discuss the evidence for the pathogenic importance of ATF6 signaling in different diseases and discuss preclinical results.
Identifiants
pubmed: 38434326
doi: 10.1016/j.heliyon.2024.e25937
pii: S2405-8440(24)01968-6
pmc: PMC10907738
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e25937Informations de copyright
© 2024 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.